Genetic risk for chronic fatigue syndrome
Bidragets beskrivning
The goal of this proposal is to understand underlying biological mechanisms behind chronic fatigue syndrome (CFS) and long-term symptoms from COVID-19 (LongCOVID) using genetics and epidemiology. A hallmark of CFS is debilitating fatigue, migrating pain, headache, fluctuating heart rate and dysautonomia. CFS diagnosis can follow infections or self-reported infection, and flu-like symptoms. Similarly, a characteristic in infection with SARS-CoV-2 is that some individuals with relatively mild infection develop long-term symptoms of severe fatigue, pain and dysautonomia similar to CFS. Currently, there is no cure and the treatment options are symptomatic. We will use genetic and epidemiology tools to explore the etiology of CFS and LongCOVID. The project has the potential to discover novel biological molecules, elucidate mechanisms from infections and autoimmunity on CFS and explore the disease burden from CFS and LongCOVID at the population level.
Visa merStartår
2022
Slutår
2027
Beviljade finansiering
Andra beslut
372129
Akademiforskarens forskningskostnader(2025)
181 775 €
353812
Akademiforskarens forskningskostnader(2022)
300 000 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Beslutfattare
Forskningsrådet för biovetenskap, hälsa och miljö
30.05.2022
30.05.2022
Övriga uppgifter
Finansieringsbeslutets nummer
350181
Vetenskapsområden
Genetik, utvecklingsbiologi, fysiologi
Forskningsområden
Perinnöllisyystiede
Identifierade teman
public health, occupational health